Opportunity Information: Apply for RFA DC 13 002
Apply for RFA DC 13 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Innovative and Novel Approaches toward Inner Ear Regenerative Therapies by Early Stage Investigators (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
- This funding opportunity was created on Feb 11, 2013 and posted on Feb 11, 2013.
- Applicants must submit their applications by Jul 18, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Public and State controlled institutions of higher education Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) County governments Public housing authorities/Indian housing authorities State governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Innovative and Novel Approaches toward Inner Ear Regenerative Therapies by Early Stage Investigators (R01)" (Funding Opportunity Number RFA-DC-13-002) is a discretionary National Institutes of Health research grant from the National Institute on Deafness and Other Communication Disorders (NIDCD). It is designed to support R01-level projects that pursue innovative, translation-oriented research aimed at regenerating neurosensory hair cells relevant to hearing and balance. In practical terms, the program is looking for studies that move beyond basic observations and instead build toward approaches that could reasonably contribute to future therapies for auditory and vestibular disorders by restoring or replacing the inner ear hair cells whose loss commonly underlies permanent sensory deficits.
A defining feature of this announcement is that it is restricted to Early Stage Investigators (ESIs) as defined by NIH policy. That means the application must come from a researcher who meets NIH's ESI criteria, and responsiveness to the announcement depends on that status. The intent is to accelerate the independence and impact of newer investigators by giving them a focused funding lane for high-need inner ear regenerative research, particularly work that is both creative and plausibly translatable. While the summary text is brief, the emphasis on "innovative and novel approaches" signals interest in fresh technical strategies, new biological insights tied to regeneration, and practical experimental designs that can bridge from mechanistic studies to preclinical development.
The overall activity falls under NIH's health research mission and is associated with CFDA number 93.173 (Research Related to Deafness and Communication Disorders). The announcement indicates there is no cost sharing or matching requirement, which generally means applicants are not expected to contribute non-federal funds as a condition of the award. The estimated total funding for the opportunity is listed as $2,000,000, implying NIDCD planned a finite pool to support a limited number of awards under this specific request for applications rather than an open-ended program.
Eligibility is broad and includes many types of domestic U.S. organizations, such as public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations other than small businesses, small businesses, and a wide range of government entities (state, county, city/township, special district governments, and certain housing authorities). The opportunity also explicitly includes eligibility for various institution types that commonly appear in NIH eligibility language, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), among others. Notably, the announcement allows applications from non-U.S. entities and foreign institutions, permits non-domestic components of U.S. organizations to apply, and allows foreign components as defined in NIH policy. That language indicates NIDCD was open to supporting strong regenerative therapy research regardless of geography, provided the application meets NIH requirements and the work aligns with the program's goals.
From an administrative timeline perspective, the opportunity was posted and created on February 11, 2013, with an original and current closing date of July 18, 2013, and an archive date of August 18, 2013. Those dates indicate this was a time-limited call with a single main deadline rather than a standing mechanism with multiple recurring receipt dates. Applicants were directed to the full official announcement on the NIH Grants Guide website, which would contain the detailed scientific scope, review criteria, budget guidance, and any special requirements for responsiveness.
For support and technical access issues, the notice provides NIH Office of Extramural Research (OER) webmaster contact information, specifically for problems accessing or linking to the funding announcement. The core takeaway is that this RFA was a targeted NIDCD initiative to fund ESI-led R01 projects that push the field toward regenerative inner ear therapies, with a particular focus on translationally relevant regeneration of auditory and vestibular neurosensory hair cells.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Innovative and Novel Approaches toward Inner Ear Regenerative Therapies by Early Stage Investigators (R01)."
What is the funding opportunity number?
The Funding Opportunity Number is RFA-DC-13-002.
Which federal agency and institute are offering this grant?
This is a discretionary National Institutes of Health (NIH) research grant offered by the National Institute on Deafness and Other Communication Disorders (NIDCD).
What type of grant mechanism is this?
This opportunity supports R01-level research projects.
What is the main scientific goal of the program?
The program is intended to support innovative, translation-oriented research aimed at regenerating neurosensory hair cells relevant to hearing and balance, with the longer-term aim of contributing to future therapies for auditory and vestibular disorders.
What kinds of inner ear conditions is this research meant to address?
The focus is on auditory and vestibular disorders where loss of inner ear hair cells commonly underlies permanent sensory deficits, and where restoring or replacing those hair cells could be therapeutically relevant.
Is the program focused on basic science or translational research?
The emphasis is on moving beyond basic observations toward translation-oriented work that can reasonably contribute to future therapies, including practical experimental designs that can bridge mechanistic studies to preclinical development.
Who is allowed to apply, and is this limited to certain investigators?
Applications are restricted to Early Stage Investigators (ESIs) as defined by NIH policy. Responsiveness to the announcement depends on the applicant meeting NIH's ESI criteria.
What is a defining feature of this announcement?
A defining feature is that it is restricted to Early Stage Investigators (ESIs), reflecting an intent to accelerate the independence and impact of newer investigators in a focused research area.
What kinds of approaches does the announcement say it is looking for?
It signals interest in "innovative and novel approaches," including fresh technical strategies, new biological insights tied to regeneration, and translation-oriented study designs relevant to inner ear hair cell regeneration.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.173 (Research Related to Deafness and Communication Disorders).
Is cost sharing or matching required?
No. The announcement indicates there is no cost sharing or matching requirement.
How much total funding is estimated for this opportunity?
The estimated total funding listed for the opportunity is $2,000,000.
Does the opportunity indicate whether the funding pool is limited?
Yes. The listed total estimate ($2,000,000) indicates NIDCD planned a finite pool intended to support a limited number of awards under this specific request for applications.
What types of U.S. organizations are eligible to apply?
Eligibility includes many types of domestic U.S. organizations, including public and private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations other than small businesses, small businesses, and a range of government entities (such as state, county, city/township, and special district governments, and certain housing authorities).
Are minority-serving institutions specifically included as eligible?
Yes. The eligibility language explicitly includes institution types commonly referenced in NIH eligibility statements, including HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), among others.
Are non-U.S. organizations or foreign institutions eligible to apply?
Yes. The announcement allows applications from non-U.S. entities and foreign institutions.
Can non-domestic components of U.S. organizations participate or apply?
Yes. The opportunity permits non-domestic components of U.S. organizations to apply.
Are foreign components allowed under NIH policy?
Yes. The announcement allows foreign components as defined in NIH policy.
When was this funding opportunity posted?
The opportunity was posted and created on February 11, 2013.
What was the application deadline?
The original and current closing date listed is July 18, 2013.
When was the opportunity archived?
The archive date is August 18, 2013.
Does this appear to have been a time-limited call?
Yes. The dates indicate this was a time-limited request for applications with a single main deadline rather than a standing opportunity with multiple recurring receipt dates.
Where were applicants directed for the full official announcement details?
Applicants were directed to the full official announcement on the NIH Grants Guide website for detailed scientific scope, review criteria, budget guidance, and any special requirements for responsiveness.
Who should be contacted for problems accessing or linking to the announcement?
For support and technical access issues (specifically problems accessing or linking to the funding announcement), the notice provides contact information for the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same category: Health
Next opportunity: Future Internet Architectures Next Phase
Previous opportunity: High Impact Neuroscience Research Resource Grants (R24)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DC 13 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DC 13 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R24) Apply for PAR 13 113 Funding Number: PAR 13 113 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R21) Apply for PAR 13 115 Funding Number: PAR 13 115 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enhancing Opioid Treatment Program Patient Continuity of Care through Data Interoperability Apply for TI 13 010 Funding Number: TI 13 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for PAR 13 116 Funding Number: PAR 13 116 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| STD Surveillance Network (SSuN) Apply for CDC RFA PS13 1306 Funding Number: CDC RFA PS13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,100,000 |
| Revision Applications for Research on Assessing the Role of Stigma in HIV Prevention and Care (R34) Apply for RFA MH 14 141 Funding Number: RFA MH 14 141 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Revision Applications for Research on Assessing the Role of Stigma in HIV Prevention and Care (R01) Apply for RFA MH 14 140 Funding Number: RFA MH 14 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Electronic Data Methods (EDM) Forum Second Phase (U18) Apply for RFA HS 13 004 Funding Number: RFA HS 13 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Rapid Hepatitis C Virus Screening and Referral Apply for TI 13 009 Funding Number: TI 13 009 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $40,000 |
| Offender Reentry Program Apply for TI 13 007 Funding Number: TI 13 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $430,000 |
| Rural Health Information Technology (HIT) Workforce Program Apply for HRSA 13 251 Funding Number: HRSA 13 251 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health Apply for CDC RFA DP13 1305 Funding Number: CDC RFA DP13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $745,000 |
| Research on Alcohol and HIV/AIDS (R03) Apply for PA 13 120 Funding Number: PA 13 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R01) Apply for PA 13 121 Funding Number: PA 13 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R21) Apply for PA 13 122 Funding Number: PA 13 122 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition Extramural Research Facilities Improvement Program (C06) Apply for RFA OD 13 003 Funding Number: RFA OD 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional and International Differences in Health and Longevity at Older Ages (R03) Apply for PA 13 123 Funding Number: PA 13 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional and International Differences in Health and Longevity at Older Ages (R21) Apply for PA 13 124 Funding Number: PA 13 124 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Regional and International Differences in Health and Longevity at Older Ages (R01) Apply for PA 13 125 Funding Number: PA 13 125 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Stroke Trials Network Regional Coordinating Stroke Centers (U10) Apply for RFA NS 13 011 Funding Number: RFA NS 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 13 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.